HOOKIPA Pharma Inc. (HOOK)
NASDAQ: HOOK · Real-Time Price · USD
2.300
-0.420 (-15.44%)
Nov 21, 2024, 4:00 PM EST - Market closed

HOOKIPA Pharma Statistics

Total Valuation

HOOKIPA Pharma has a market cap or net worth of $27.97 million. The enterprise value is -$24.14 million.

Market Cap 27.97M
Enterprise Value -24.14M

Important Dates

The last earnings date was Thursday, November 14, 2024, after market close.

Earnings Date Nov 14, 2024
Ex-Dividend Date n/a

Share Statistics

HOOKIPA Pharma has 12.05 million shares outstanding. The number of shares has increased by 44.77% in one year.

Current Share Class 9.66M
Shares Outstanding 12.05M
Shares Change (YoY) +44.77%
Shares Change (QoQ) +0.35%
Owned by Insiders (%) 0.13%
Owned by Institutions (%) 23.27%
Float 6.95M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.66
Forward PS n/a
PB Ratio 0.46
P/TBV Ratio 0.43
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.26, with a Debt / Equity ratio of 0.04.

Current Ratio 3.26
Quick Ratio 2.97
Debt / Equity 0.04
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -897.10

Financial Efficiency

Return on equity (ROE) is -51.99% and return on invested capital (ROIC) is -32.96%.

Return on Equity (ROE) -51.99%
Return on Assets (ROA) -20.89%
Return on Capital (ROIC) -32.96%
Revenue Per Employee $279,324
Profits Per Employee -$242,296
Employee Count 179
Asset Turnover 0.37
Inventory Turnover n/a

Taxes

In the past 12 months, HOOKIPA Pharma has paid $163,000 in taxes.

Income Tax 163,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -54.24% in the last 52 weeks. The beta is 0.83, so HOOKIPA Pharma's price volatility has been lower than the market average.

Beta (5Y) 0.83
52-Week Price Change -54.24%
50-Day Moving Average 3.90
200-Day Moving Average 6.14
Relative Strength Index (RSI) 15.57
Average Volume (20 Days) 66,497

Short Selling Information

The latest short interest is 36,244, so 0.30% of the outstanding shares have been sold short.

Short Interest 36,244
Short Previous Month 26,040
Short % of Shares Out 0.30%
Short % of Float 0.52%
Short Ratio (days to cover) 1.08

Income Statement

In the last 12 months, HOOKIPA Pharma had revenue of $50.00 million and -$43.37 million in losses. Loss per share was -$3.55.

Revenue 50.00M
Gross Profit -9.91M
Operating Income -45.75M
Pretax Income -48.43M
Net Income -43.37M
EBITDA -42.42M
EBIT -45.75M
Loss Per Share -$3.55
Full Income Statement

Balance Sheet

The company has $59.75 million in cash and $2.83 million in debt, giving a net cash position of $56.93 million or $4.72 per share.

Cash & Cash Equivalents 59.75M
Total Debt 2.83M
Net Cash 56.93M
Net Cash Per Share $4.72
Equity (Book Value) 71.80M
Book Value Per Share 5.96
Working Capital 64.59M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$67.26 million and capital expenditures -$614,000, giving a free cash flow of -$67.88 million.

Operating Cash Flow -67.26M
Capital Expenditures -614,000
Free Cash Flow -67.88M
FCF Per Share -$5.63
Full Cash Flow Statement

Margins

Gross margin is -19.81%, with operating and profit margins of -91.51% and -86.74%.

Gross Margin -19.81%
Operating Margin -91.51%
Pretax Margin -86.42%
Profit Margin -86.74%
EBITDA Margin -84.84%
EBIT Margin -91.51%
FCF Margin -148.53%

Dividends & Yields

HOOKIPA Pharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -44.77%
Shareholder Yield -44.77%
Earnings Yield -139.73%
FCF Yield -218.68%

Analyst Forecast

The average price target for HOOKIPA Pharma is $38.75, which is 1,570.26% higher than the current price. The consensus rating is "Strong Buy".

Price Target $38.75
Price Target Difference 1,570.26%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) 58.88%
EPS Growth Forecast (5Y) n/a
Stock Forecasts

Stock Splits

The last stock split was on July 10, 2024. It was a reverse split with a ratio of 0.1:1.

Last Split Date Jul 10, 2024
Split Type Reverse
Split Ratio 0.1:1

Scores

Altman Z-Score n/a
Piotroski F-Score 2